Actively Recruiting

Age: 10Years +
All Genders
NCT06596746

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Led by Casa di Cura San Raffaele Cassino · Updated on 2024-09-19

600

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

Sponsors

C

Casa di Cura San Raffaele Cassino

Lead Sponsor

I

IRCCS San Raffaele Roma

Collaborating Sponsor

AI-Summary

What this Trial Is About

MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry tests will be analysed to carry out statistical investigations and predictive analyses, also using artificial intelligence systems, which allow the identification of new early markers of diagnosis and prognosis of neurodegenerative diseases.

CONDITIONS

Official Title

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Who Can Participate

Age: 10Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with Parkinson's Disease according to the UK Parkinson's Disease Society Brain Bank criteria
  • Patients diagnosed with Movement Disorders not related to Parkinson's Disease, including Multiple System Atrophy, Progressive Supranuclear Palsy, and Essential Tremor
  • Patients diagnosed with cognitive impairment or dementia, including probable Lewy Body Dementia, Alzheimer's Disease, Mild Cognitive Decline, or subjective memory complaints
  • Willingness to participate in the study, understand procedures, and provide informed consent
Not Eligible

You will not qualify if you...

  • No restrictions based on age, illness severity, or cognitive impairment, provided the participant can complete the study assessments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

San Raffaele Cassino

Cassino, Frosinone, Italy, 03043

Actively Recruiting

Loading map...

Research Team

M

Maria Francesca De Pandis, MD, PhD, Neurologist

CONTACT

M

Maria Gaglione

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here